Based on the discovery that estradiol reduces PD-L1 expression in colon tumor tissues to impede tumor growth, researchers also observed that pre-treatment with estradiol before αPD-L1 therapy led to alterations in the gut microbiota composition and diversity in male mice (Song et al., 2020b, 2022, 2023a). Here, CD274 is linked to neoplasm.